145 related articles for article (PubMed ID: 8932807)
1. Prophylaxis and pre-emptive therapy of bacterial infections following allogeneic bone marrow transplantation in children.
Vossen JM; de Tollenaer S; van Weel-Sipman MH
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():93-6. PubMed ID: 8932807
[No Abstract] [Full Text] [Related]
2. Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.
Krüger W; Rüssmann B; Kröger N; Salomon C; Ekopf N; Elsner HA; Kaulfers PM; Mack D; Fuchs N; Dürken M; Kabisch H; Erttmann R; Zander AR
Bone Marrow Transplant; 1999 Mar; 23(6):589-97. PubMed ID: 10217190
[TBL] [Abstract][Full Text] [Related]
3. Early infectious complications in children undergoing BMT.
Viscoli C; Castagnola E; Moroni C; Boni L; Dallorso S; Garaventa A; Lanino E; Dini G
Bone Marrow Transplant; 1991; 7 Suppl 3():42-7. PubMed ID: 1855088
[No Abstract] [Full Text] [Related]
4. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
Ringdén O; Andström EE; Remberger M; Dahllöf G; Svahn BM; Tollemar J
Pediatr Transplant; 1997 Nov; 1(2):124-9. PubMed ID: 10084772
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
6. Pre-emptive ganciclovir treatment can play a role in restoration of hematopoiesis after allogeneic bone marrow transplantation.
Choi JH; Kim DW; Cho SG; Yoo JH; Jeong DC; Han CW; Shin WS; Min WS; Kim HK; Kim CC; Kim DJ
Bone Marrow Transplant; 1997 Jan; 19(2):187-90. PubMed ID: 9116619
[TBL] [Abstract][Full Text] [Related]
7. [Infections and bone marrow autograft carried out for leukemias in children. Apropos of 47 cases].
Amsallem D; Plouvier E; Estavoyer JM; Leroy J; Talon D; Lab M; Hervé P; Noir A
Arch Fr Pediatr; 1988; 45(6):393-7. PubMed ID: 3064729
[TBL] [Abstract][Full Text] [Related]
8. Intracerebral aspergillosis following allogeneic marrow transplantation responding to treatment with non-liposomal amphotericin B and rifampicin.
Proctor SJ; Jackson GH
Br J Haematol; 1997 Sep; 98(4):1052-3. PubMed ID: 9326214
[No Abstract] [Full Text] [Related]
9. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
Wingard JR
Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
[TBL] [Abstract][Full Text] [Related]
10. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
[TBL] [Abstract][Full Text] [Related]
11. Infections in children undergoing allogeneic bone marrow transplantation in India.
George B; Mathews V; Viswabandya A; Srivastava A; Chandy M
Pediatr Transplant; 2006 Feb; 10(1):48-54. PubMed ID: 16499587
[TBL] [Abstract][Full Text] [Related]
12. Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts.
Vanneaux V; Foïs E; Robin M; Rea D; de Latour RP; Biscay N; Chantre E; Robert I; Wargnier A; Traineau R; Benbunan M; Marolleau J; Socié G; Larghero J
Cytotherapy; 2007; 9(5):508-13. PubMed ID: 17786612
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of antibacterial prophylaxis with non-absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation.
Koh S; Yamada K; Nishimoto M; Hayashi Y; Koh H; Nakashima Y; Nakane T; Hirose A; Nakamae M; Kakeya H; Hino M; Nakamae H
Transpl Infect Dis; 2015 Oct; 17(5):647-54. PubMed ID: 26134140
[TBL] [Abstract][Full Text] [Related]
14. Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea.
Poetker DM; Lindstrom DR; Patel NJ; Conley SF; Flanary VA; Link TR; Kerschner JE
Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1294-8. PubMed ID: 17178938
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal infections in children after transplantation.
Schutze GE; Mason EO; Wald ER; Barson WJ; Bradley JS; Tan TQ; Kim KS; Givner LB; Yogev R; Kaplan SL
Clin Infect Dis; 2001 Jul; 33(1):16-21. PubMed ID: 11389489
[TBL] [Abstract][Full Text] [Related]
16. A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.
Slavin MA; Grigg AP; Schwarer AP; Szer J; Spencer A; Sainani A; Thursky KA; Roberts AW
Bone Marrow Transplant; 2007 Jul; 40(2):157-63. PubMed ID: 17468774
[TBL] [Abstract][Full Text] [Related]
17. A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy.
Avery RK; Adal KA; Longworth DL; Bolwell BJ
Bone Marrow Transplant; 2000 Oct; 26(7):763-7. PubMed ID: 11042658
[TBL] [Abstract][Full Text] [Related]
18. Successful program to prevent aspergillus infections in children undergoing marrow transplantation: use of nasal amphotericin.
Trigg ME; Morgan D; Burns TL; Kook H; Rumelhart SL; Holida MD; Giller RH
Bone Marrow Transplant; 1997 Jan; 19(1):43-7. PubMed ID: 9012930
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus and adenovirus infections and diseases among 75 paediatric unrelated allogeneic bone marrow transplant recipients.
Morfin F; Boucher A; Najioullah F; Bertrand Y; Bleyzac N; Poitevin-Later F; Bienvenu F; Simonet V; Galambrun C; Philippe N; Aymard M; Thouvenot D; Souillet G
J Med Virol; 2004 Feb; 72(2):257-62. PubMed ID: 14695667
[TBL] [Abstract][Full Text] [Related]
20. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
